Abstract
Amorphous materials have always been an essential part of pharmaceutical research They are important because of their characteristic solubility characteristics, common occurrence, and physicochemical instability relative to corresponding crystals. Some pharmaceutical agents have a tendency to exist as amorphous solids, while others require prevention of their crystallization to remain in the amorphous state in order to achieve desire characteristics. Amorphous solids can be stabilized by some common pharmaceutical processes like solid dispersion technique, solvent evaporation, milling, lipid dispersion. This article reviews the methodologies and approaches for stabilization of amorphous form.
Keywords: Amorphous solid, crystallization, dispersion techniques, milling, physicochemical instability, stabilization
Current Drug Therapy
Title:Approaches to Stabilize Amorphous Form - A Review
Volume: 7 Issue: 4
Author(s): Kisan R. Jadhav, Sharad S. Pacharane, Priti P. Pednekar, Praveen V. Koshy and Vilasrao J. Kadam
Affiliation:
Keywords: Amorphous solid, crystallization, dispersion techniques, milling, physicochemical instability, stabilization
Abstract: Amorphous materials have always been an essential part of pharmaceutical research They are important because of their characteristic solubility characteristics, common occurrence, and physicochemical instability relative to corresponding crystals. Some pharmaceutical agents have a tendency to exist as amorphous solids, while others require prevention of their crystallization to remain in the amorphous state in order to achieve desire characteristics. Amorphous solids can be stabilized by some common pharmaceutical processes like solid dispersion technique, solvent evaporation, milling, lipid dispersion. This article reviews the methodologies and approaches for stabilization of amorphous form.
Export Options
About this article
Cite this article as:
R. Jadhav Kisan, S. Pacharane Sharad, P. Pednekar Priti, V. Koshy Praveen and J. Kadam Vilasrao, Approaches to Stabilize Amorphous Form - A Review, Current Drug Therapy 2012; 7 (4) . https://dx.doi.org/10.2174/157488512804999118
DOI https://dx.doi.org/10.2174/157488512804999118 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
How Should We Deal with Missing Data in Clinical Trials Involving Alzheimers Disease Patients?
Current Alzheimer Research Anti-HIV Drug Distribution to the Central Nervous System
Current Pharmaceutical Design Current Treatments of Muco-Cutaneous Herpes Simplex Virus Infections
Current Medicinal Chemistry - Anti-Infective Agents New Prospective for Redox Modulation Mediated by Organo selenium and Organotellurium Compounds
Current Organic Chemistry Current and Future Prospective of a Versatile Moiety: Imidazole
Current Drug Targets Derivatives as 5HT1A Receptor Ligands-Past and Present
Current Medicinal Chemistry Real Time Analysis of Neurotransmitters in the Brain Using a Micro-Electrode System
Current Neurovascular Research Meet Our Associate Editor
Current Alzheimer Research Benzodiazepines, Amphetamines, Testosterone, and Sildenafil as New Candidate Drugs for Sexual Interest, Desire and/or Arousal Disorder
Current Psychopharmacology P2X7 Receptors: Channels, Pores and More
CNS & Neurological Disorders - Drug Targets Pain and Obesity in the Older Adult
Current Pharmaceutical Design Curcumin Nanomedicine: A Road to Cancer Therapeutics
Current Pharmaceutical Design Homology Modeling of Adenosine A2A Receptor and Molecular Docking for Exploration of Appropriate Potent Antagonists for Treatment of Parkinsons Disease
Current Aging Science Therapeutic Interventions Targeting Beta Amyloid Pathogenesis in an Aging Dog Model
Current Neuropharmacology MicroRNAs and Diabetes Mellitus Type 1
Current Diabetes Reviews Pain and Child: A Translational Hypothesis on the Pathophysiology of a Mild Type-2 Diabetes Model
Endocrine, Metabolic & Immune Disorders - Drug Targets Advances in Neuroimaging for HIV-1 Associated Neurological Dysfunction: Clues to the Diagnosis, Pathogenesis and Therapeutic Monitoring
Current HIV Research Paullones as Inhibitors of Protein Kinases
Current Topics in Medicinal Chemistry Association between <i>Toxoplasma gondii</i> Infection and Headache: A Systematic Review and Meta-Analysis
Infectious Disorders - Drug Targets Immune Abnormalities and Endotoxemia in Patients with Ulcerative Colitis and in Their First Degree Relatives: Attempts at Neutralizing Endotoxin- Mediated Effects
Current Pharmaceutical Design